Literature DB >> 9030766

Nicotinamide riboside, an unusual, non-typical, substrate of purified purine-nucleoside phosphorylases.

B Wielgus-Kutrowska1, E Kulikowska, J Wierzchowski, A Bzowska, D Shugar.   

Abstract

Nicotinamide 1-beta-D-riboside (Nir), the cationic, reducible moiety of the coenzyme NAD+, has been confirmed as an unusual substrate for purified purine-nucleoside phosphorylase (PNP) from a mammalian source (calf spleen). It is also a substrate of the enzyme from Escherichia coli. The Km values at pH 7, 1.48 mM and 0.62 mM, respectively, were 1-2 orders of magnitude higher than for the natural substrate inosine, but the Vmax values were comparable, 96% and 35% that for Ino. The pseudo first-order rate constants, Vmax/Km, were 1.1% and 2.5% for the calf spleen and E. coli enzymes. The aglycon, nicotinamide, was neither a substrate nor an inhibitor of PNP. Nir was a weak inhibitor of inosine phosphorolysis catalyzed by both enzymes, with Ki values close to the Km for its phosphorolysis, consistent with simple competitive inhibition; this was further confirmed by Dixon plots. Phosphorolysis of the fluorescent positively charged substrate 7-methylguanosine was also inhibited in a competitive manner by both Ino and Nir. Phosphorolysis of Nir by both enzymes was inhibited competitively by several specific inhibitors of calf spleen and E. coli PNP, with Ki values similar to those for inhibition of other natural substrates. The pH dependence of the kinetic constants for the phosphorolysis of Nir and of a variety of other substrates, was extensively investigated, particularly in the alkaline pH range, where Nir exhibited abnormally high substrate activity relative to the reduced reaction rates of both enzymes towards other anionic or neutral substrates. The overall results are discussed in relation to present concepts regarding binding and phosphorolysis of substrates by PNP based on crystallographic data of enzyme-inhibitor complexes, and current studies on enzymatic and nonenzymatic mechanisms of the cleavage of the Nir glycosidic bond.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9030766     DOI: 10.1111/j.1432-1033.1997.0408a.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Nicotinamide riboside-amino acid conjugates that are stable to purine nucleoside phosphorylase.

Authors:  Faisal Hayat; Marie E Migaud
Journal:  Org Biomol Chem       Date:  2020-04-15       Impact factor: 3.876

2.  Nicotinamide riboside and nicotinic acid riboside salvage in fungi and mammals. Quantitative basis for Urh1 and purine nucleoside phosphorylase function in NAD+ metabolism.

Authors:  Peter Belenky; Kathryn C Christensen; Francesca Gazzaniga; Alexandre A Pletnev; Charles Brenner
Journal:  J Biol Chem       Date:  2008-11-11       Impact factor: 5.157

3.  Chemo-enzymatic synthesis of isotopically labeled nicotinamide riboside.

Authors:  Ai Tran; Ryota Yokose; Yana Cen
Journal:  Org Biomol Chem       Date:  2018-05-15       Impact factor: 3.876

4.  4-Pyridone-3-carboxamide-1-β-D-ribonucleoside triphosphate (4PyTP), a novel NAD metabolite accumulating in erythrocytes of uremic children: a biomarker for a toxic NAD analogue in other tissues?

Authors:  Elena Synesiou; Lynnette D Fairbanks; H Anne Simmonds; Ewa M Slominska; Ryszard T Smolenski; Elizabeth A Carrey
Journal:  Toxins (Basel)       Date:  2011-06-07       Impact factor: 4.546

5.  New function for Escherichia coli xanthosine phophorylase (xapA): genetic and biochemical evidences on its participation in NAD(+) salvage from nicotinamide.

Authors:  Wei-Ren Dong; Cen-Cen Sun; Guan Zhu; Shi-Hua Hu; Li-Xin Xiang; Jian-Zhong Shao
Journal:  BMC Microbiol       Date:  2014-02-08       Impact factor: 3.605

Review 6.  The human NAD metabolome: Functions, metabolism and compartmentalization.

Authors:  Andrey Nikiforov; Veronika Kulikova; Mathias Ziegler
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-04-02       Impact factor: 8.250

7.  An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers.

Authors:  Sophia E Airhart; Laura M Shireman; Linda J Risler; Gail D Anderson; G A Nagana Gowda; Daniel Raftery; Rong Tian; Danny D Shen; Kevin D O'Brien
Journal:  PLoS One       Date:  2017-12-06       Impact factor: 3.240

Review 8.  Nicotinamide Riboside-The Current State of Research and Therapeutic Uses.

Authors:  Mario Mehmel; Nina Jovanović; Urs Spitz
Journal:  Nutrients       Date:  2020-05-31       Impact factor: 5.717

9.  Crystallographic snapshots of ligand binding to hexameric purine nucleoside phosphorylase and kinetic studies give insight into the mechanism of catalysis.

Authors:  Zoran Štefanić; Marta Narczyk; Goran Mikleušević; Saša Kazazić; Agnieszka Bzowska; Marija Luić
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.